NCT00429910View on ClinicalTrials.gov

Natural History Study of Patients With Chronic Myelogenous Leukemia

CompletedOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Leukemia
Trial Locations (1)

02115

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER

NCT00429910 - Natural History Study of Patients With Chronic Myelogenous Leukemia | Biotech Hunter | Biotech Hunter